Irbesartan-d3

• CAT Number: R006084
• CAS Number: 1185120-76-6
• Molecular Formula: C25H28N6O
• Molecular Weight: 431.558
• Purity: ≥95%
• Synonyms: 2-Butyl-3-[[2’-(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one-d3
• Storage: Room temperature
• IUPAC Name: 3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-(4,4,4-trideuteriobutyl)-1,3-diazaspiro[4.4]non-1-en-4-one
• InChI: InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)/i1D3
• InChIKey: YOSHYTLCDANDAN-FIBGUPNXSA-N
• SMILES: [2H]C([2H])([2H])CCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5

Irbesartan-d3 is a deuterated version of Irbesartan, a widely used antihypertensive agent. This compound features three deuterium atoms, making it an ideal internal standard for quantitative LC-MS analysis in pharmaceutical research. Irbesartan-d3 is essential for studying the pharmacokinetics, metabolism, and bioavailability of Irbesartan, providing precise and reliable data. Its stable isotope labeling enhances the accuracy of analytical results, supporting drug development and therapeutic monitoring. This high-purity compound integrates seamlessly into existing protocols, offering a robust and cost-effective solution for advanced research in hypertension treatment.